logo

Saudi Arabia Respiratory Devices Market Size (2024 - 2029)

The Saudi Arabia respiratory devices market is projected to experience growth due to increased demand driven by the COVID-19 pandemic and the rising prevalence of respiratory disorders such as asthma and tuberculosis. Government initiatives and the need for advanced medical equipment have further contributed to the market's expansion. Additionally, product approvals, launches, and strategic partnerships by key players are expected to enhance the market's capacity and accessibility. However, the high cost of these devices may pose a challenge to market growth.

Home Market Analysis Healthcare Research Medical Devices Research Medical Supplies Research Medical Consumables Research Respiratory Supplies Research Saudi Arabia Respiratory Devices Industry Market Size

Market Size of Saudi Arabia Respiratory Devices Industry

respiratory
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 5.50 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

Saudi Arabia Respiratory Devices Market Analysis

The Saudi Arabia respiratory devices market is expected to register a CAGR of 5.5% during the forecast period.

Respiratory devices, such as ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators are witnessed the highest demand, as they are widely being used for COVID-19 patients. The article titled "Bed Surge Capacity in Saudi Hospitals During the COVID-19 Pandemic" published in Cambridge University Press Public Health Emergency Collection in April 2021 stated that the rate of hospital admission of COVID-19 patients ranged from 11% to 62% over the period from April to September 2020. The Saudi authority has obliged mask-wearing in public places to reduce the risk of viral transmission in the community. It stated that there was a high demand for ICU beds with ventilators for the management of COVID-19-positive patients. The ministry of health (MOH) supplied an additional 3728 hospital beds accompanied by mechanical ventilators to hospitals created to face the COVID-19 outbreak. In the ICU context, the number of extracorporeal membrane oxygenation machines within Saudi Arabia was 24 machines. This indicated the immense need for respiratory devices, such as ventilators in the country impacted by COVID-19. Hence, it is observed that the market studied is positively impacted by the covid pandemic.

In addition, the increasing prevalence of respiratory disorders, rising government initiatives, and large patient populations are actively affecting the growth of the studied market.

The article titled "The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children" published in the Annals of Thoracic Medicine in January 2021stated that asthma is one of the most prevalent chronic illnesses in Saudi Arabia, and local reports suggested that the prevalence of asthma is increasing. Based on studies undertaken over the past three decades, it was claimed that the overall prevalence of asthma in Saudi Arabian children ranges from 8% to 25%. Also, an article titled "A Saudi Arabian Public Health Perspective of Tuberculosis" published in International Journal of Environmental Research and Public Health in September 2021 stated that M. tuberculosis is endemic in the Middle East with incidence of 14 per 100,000 people in Kingdom of Saudi Arabia. The high burden of respiratory diseases like asthma and tuberculosis is projected to boost the demand for respiratory devices for the management of diseases and ultimately augment the market growth.

Furthermore, the product approvals, launches, partnerships and acquisitons by the key market players are projected to augment the market growth in the country. For instance, in July 2020, Sedana Medical AB received market approval for its medical device AnaConDa in Saudi Arabia and the company signed distribution agreements for sales in the Middle East with Techno Orbits in Saudi Arabia. The anaesthetic conserving device AnaConDa is a device that delivers a safe sedative dose to a patient using existing critical care ventilators, common syringe pumps and gas monitors. Also, in March 2021, Philips partnered for three-year with the Middle East Healthcare Company (MEAHCO) to launch state-of-the-art sleep disorder management services in Saudi Arabia through Saudi German Health Group. The partnership is intended to offer innovative solutions to patients suffering from severe disorders such as Obstructive Sleep Apnea (OSA). Such approvals and partnerships by key market players are expected to increase the utility of respiratory devices in the country and augment the market growth.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. however, the high cost of devices is likely to impede the market growth.

Saudi Arabia Respiratory Devices Industry Segmentation

As per the scope of the report, Respiratory devices include respiratory diagnostic and monitoring devices, therapeutic devices, and disposables for administering long-term artificial respiration. The Saudi Arabia Respiratory Devices Market is segmented by Type, Diagnostic and Monitoring Devices (Spirometers, Sleep Test Devices, Peak Flow Meters, Pulse Oximeters, Capnographs, and Other Diagnostic and Monitoring Devices), Therapeutic Devices (CPAP Devices, BiPAP Devices, Humidifiers, Nebulizers, Oxygen Concentrators, Ventilators, Inhalers, and Other Therapeutic Devices), and Disposables (Masks, Breathing Circuits, and Other Disposables). The report offers the value (in USD million) for the above segments.

By Type
By Diagnostic and Monitoring Devices
Spirometers
Sleep Test Devices
Peak Flow Meters
Pulse Oximeters
Capnographs
Other Diagnostic and Monitoring Devices
By Therapeutic Devices
CPAP Devices
BiPAP Devices
Humidifiers
Nebulizers
Oxygen Concentrators
Ventilators
Inhalers
Other Therapeutic Devices
By Disposables
Masks
Breathing Circuits
Other Disposables
Need A Different Region Or Segment?
Customize Now

Saudi Arabia Respiratory Devices Market Size Summary

The Saudi Arabia respiratory devices market is poised for significant growth, driven by the increasing demand for devices such as ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators, particularly in the wake of the COVID-19 pandemic. The pandemic highlighted the critical need for these devices, as evidenced by the surge in hospital admissions and the subsequent requirement for ICU beds equipped with ventilators. The government's proactive measures, including the supply of additional hospital beds and mechanical ventilators, underscored the essential role of respiratory devices in managing COVID-19 cases. Beyond the pandemic, the market is further bolstered by the rising prevalence of respiratory disorders like asthma and tuberculosis, which necessitate the use of these devices for effective disease management. Government initiatives and a large patient population are also contributing to the market's expansion.

The competitive landscape of the Saudi Arabia respiratory devices market is characterized by the presence of both international and regional companies, with key players such as Dragerwerk AG, Fisher & Paykel Healthcare Limited, General Electric Company (GE Healthcare), GSK plc, Invacare Corporation, Koninklijke Philips N.V, Medtronic PLC, and ResMed Inc. These companies are actively engaged in product approvals, launches, partnerships, and acquisitions to enhance their market presence. Notable developments include Sedana Medical AB's market approval for its AnaConDa device and Philips' partnership with the Middle East Healthcare Company to offer advanced sleep disorder management services. Such strategic initiatives are expected to increase the utility of respiratory devices in the country, driving market growth. However, the high cost of these devices may pose a challenge to market expansion.

Explore More

Saudi Arabia Respiratory Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Respiratory Disorders

      2. 1.2.2 Rising Government Initiatives and Large Patient Population

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Devices

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Type

      1. 2.1.1 By Diagnostic and Monitoring Devices

        1. 2.1.1.1 Spirometers

        2. 2.1.1.2 Sleep Test Devices

        3. 2.1.1.3 Peak Flow Meters

        4. 2.1.1.4 Pulse Oximeters

        5. 2.1.1.5 Capnographs

        6. 2.1.1.6 Other Diagnostic and Monitoring Devices

      2. 2.1.2 By Therapeutic Devices

        1. 2.1.2.1 CPAP Devices

        2. 2.1.2.2 BiPAP Devices

        3. 2.1.2.3 Humidifiers

        4. 2.1.2.4 Nebulizers

        5. 2.1.2.5 Oxygen Concentrators

        6. 2.1.2.6 Ventilators

        7. 2.1.2.7 Inhalers

        8. 2.1.2.8 Other Therapeutic Devices

      3. 2.1.3 By Disposables

        1. 2.1.3.1 Masks

        2. 2.1.3.2 Breathing Circuits

        3. 2.1.3.3 Other Disposables

Saudi Arabia Respiratory Devices Market Size FAQs

The Saudi Arabia Respiratory Devices Market is projected to register a CAGR of 5.5% during the forecast period (2024-2029)

Dragerwerk AG, Fisher & Paykel Healthcare Limited., Koninklijke Philips N.V, GSK plc. and General Electric Company (GE Healthcare) are the major companies operating in the Saudi Arabia Respiratory Devices Market.

Saudi Arabia Respiratory Equipment Market Report Snapshots

Saudi Arabia Respiratory Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)